Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

Share Price is delayed by 15 minutes
Get Live Data
29.00    0.00 (0.00%)
Bid:
28.00
Ask:
30.00
Spread: 2.00 (7.143%)
Market Cap: £52.44m
IKA Live PriceLast checked at - London Stock Exchange

Intraday Ilika Plc Share Chart

Higher Power Cell Performance

1 Nov 2018 07:00

RNS Number : 8999F
Ilika plc
01 November 2018
 

 

Ilika Plc

("Ilika" or the "Company")

 

 Higher Power Cell Performance

 

Ilika plc (AIM: IKA), the advanced solid-state battery technology and materials innovation company, announces significant improvement in the power capability of its Stereaxâ M250 cells.

 

In 2016, Ilika launched the Stereaxâ M250, the first of its family of solid-state batteries for powering autonomous wireless sensors. The Stereaxâ M250 is a thin (0.7 mm) solid-state battery with 250 uAh capacity and 5 mA peak current sufficient to power wireless communication technologies such as Bluetooth® Low Energy.

 

Now, the rate capability, which is the ability to provide even higher peak and continuous currents, has been improved through the optimisation of the manufacturing process. An increased continuous current of 20C (meaning the entire cell can be charged or discharged in three minutes) has been recorded with good cycle life. This is twice the previously qualified continuous current for this battery and 10 times the maximum continuous current typically specified for conventional lithium ion batteries. This means that the improved Stereaxâ M250 can now provide higher power and support greater functionality to autonomous sensors such as providing power for longer range communications protocols like LoRaWANTM.

 

 

For more information contact:

 

Ilika plc

 

www.ilika.com

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

Liberum Capital Limited

Tel: 020 3100 2000

Andrew Godber, Cameron Duncan

Trystan Cullen, William Hall

Walbrook PR Ltd

Tel: 020 7933 8780 / ilika@walbrookpr.com

Paul Cornelius

Mob: 07866 384 707

Lianne Cawthorne

Mob: 07584 391 303

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAWGGMGUUPRGWG
Date   Source Headline
17th Sep 20134:09 pmRNSResult of AGM
17th Sep 20137:00 amRNSAGM Statement
16th Sep 20137:00 amRNSTwo New Customers in Europe
23rd Aug 20131:25 pmRNSPosting of Annual Report & Notice of AGM
2nd Aug 20135:02 pmRNSConversion of Securities
30th Jul 20137:00 amRNSContract Renewals and Grant Award
19th Jul 20132:50 pmRNSHolding(s) in Company
19th Jul 201311:17 amRNSHolding(s) in Company
18th Jul 20137:00 amRNS£3.3 million EPSRC Grant Award to Southampton Univ
15th Jul 20137:00 amRNSFinal Results
21st May 20131:09 pmRNSHolding(s) in Company
20th May 20137:00 amRNSDirectorate Change and Conversion of Securities
17th May 20133:57 pmRNSPlacing - Replacement
17th May 20137:00 amRNSPlacing
1st May 20137:00 amRNSFuel Cell Catalyst Patent Granted in Japan
22nd Apr 20137:00 amRNSContract with new European Customer
16th Apr 20137:00 amRNSTrading Update
21st Feb 20137:00 amRNSRenewal of Contract
29th Jan 20137:00 amRNSCompletion of Laboratory Facility Expansion
18th Jan 20133:28 pmRNSHolding(s) in Company
17th Jan 20135:46 pmRNSHolding(s) in Company
17th Jan 201311:16 amRNSHolding(s) in Company
15th Jan 20135:21 pmRNSHolding(s) in Company
10th Jan 20137:00 amRNSInterim Results
21st Dec 20127:00 amRNSGrant of Fuel Cell Catalyst Patent
18th Dec 20121:41 pmRNSCompletion of Disposal
17th Dec 20127:00 amRNSConversion of Securities
11th Dec 20127:00 amRNSRenewal of Contract
29th Nov 20124:44 pmRNSHolding(s) in Company
28th Nov 20125:00 pmRNSHolding(s) in Company
27th Nov 20122:18 pmRNSHolding(s) in Company
19th Nov 20127:00 amRNSEnergizer Relationship Update
22nd Oct 20127:00 amRNSTrading Update
5th Oct 20127:00 amRNSHolding(s) in Company
5th Oct 20127:00 amRNSTotal Voting Rights
18th Sep 20127:00 amRNSDiscontinuing of wound care products and services
14th Sep 20127:00 amRNSCarbon Trust Investment
7th Sep 20121:27 pmRNSResult of AGM
7th Sep 20127:00 amRNSAGM Statement
9th Aug 20127:00 amRNSPosting of Annual Report & Notice of AGM
19th Jul 20127:00 amRNSFinal Results
14th Jun 20127:14 amRNSChange of Adviser
1st Jun 201210:01 amRNSTotal Voting Rights
18th May 20127:00 amRNSTrading Update
17th May 20127:00 amRNSConversion of Securities
2nd May 20127:00 amRNSVapour Deposition Method US Patent Grant
1st May 20123:00 pmRNSHolding(s) in Company
30th Apr 201210:27 amRNSDirector's Dealings
30th Apr 201210:22 amRNSTotal Voting Rights
25th Apr 20122:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.